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Abstract
Background: New electronic cohort (e-Cohort) study designs provide resource-effective methods for collecting participant
data. It is unclear if implementing an e-Cohort study without direct, in-person participant contact can achieve successful participation
rates.
Objective: The objective of this study was to compare 2 distinct enrollment methods for setting up mobile health (mHealth)
devices and to assess the ongoing adherence to device use in an e-Cohort pilot study.
Methods: We coenrolled participants from the Framingham Heart Study (FHS) into the FHS–Health eHeart (HeH) pilot study,
a digital cohort with infrastructure for collecting mHealth data. FHS participants who had an email address and smartphone were
randomized to our FHS-HeH pilot study into 1 of 2 study arms: remote versus on-site support. We oversampled older adults (age
≥65 years), with a target of enrolling 20% of our sample as older adults. In the remote arm, participants received an email containing
a link to enrollment website and, upon enrollment, were sent 4 smartphone-connectable sensor devices. Participants in the on-site
arm were invited to visit an in-person FHS facility and were provided in-person support for enrollment and connecting the devices.
Device data were tracked for at least 5 months.
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Results: Compared with the individuals who declined, individuals who consented to our pilot study (on-site, n=101; remote,
n=93) were more likely to be women, highly educated, and younger. In the on-site arm, the connection and initial use of devices
was ≥20% higher than the remote arm (mean percent difference was 25% [95% CI 17-35] for activity monitor, 22% [95% CI
12-32] for blood pressure cuff, 20% [95% CI 10-30] for scale, and 43% [95% CI 30-55] for electrocardiogram), with device
connection rates in the on-site arm of 99%, 95%, 95%, and 84%. Once connected, continued device use over the 5-month study
period was similar between the study arms.
Conclusions: Our pilot study demonstrated that the deployment of mobile devices among middle-aged and older adults in the
context of an on-site clinic visit was associated with higher initial rates of device use as compared with offering only remote
support. Once connected, the device use was similar in both groups.
(JMIR Mhealth Uhealth 2019;7(9):e13238)  doi: 10.2196/13238
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Introduction
Background
Recent advances in mobile health (mHealth) technology have
improved the feasibility of collecting digital data and have the
potential to revolutionize both research and health care delivery
[1-4]. The term mHealth technology refers to the use of
smartphones and other mobile devices for personal health
monitoring, health care delivery, or research [5]. Expert
recommendations from the National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI) advocated
for using innovative approaches, such as study designs that
utilize mHealth technology, to provide new opportunities for
population science [6]. Innovative electronic cohort (e-Cohort)
study designs that incorporate mHealth technology into
traditional cohort studies have been proposed, minimizing the
requirement of physical resources by collecting data remotely
(reducing or completely eliminating in-person clinical
examinations) [7-10]. In 2015, the NIH funded a national
resource to mobilize research by creating an infrastructure for
conducting research using mHealth technology and has recently
initiated the All of Us Research Program (formerly called the
Precision Medicine Initiative) [11]. The All of Us program is
a large, national study, with the goal of recruiting 1 million
participants, which differs from other national cohorts such as
the United Kingdom Biobank Study [12], by allowing for
electronic (remote) enrollment. Successful recruitment in
previous e-Cohort studies such as Health eHeart (HeH) Study
and MyHeart Counts, which do not require on-site visits [13,14],
have paved the way for new, large e-Cohorts such as All of Us.
The e-Cohort approach may provide a cost-effective
methodology to remotely collect population-level data outside
of standard research clinic settings, using mHealth devices and
internet-based questionnaires [7-10], but may introduce
substantial selection bias beyond that of typical research studies
[13,15]. Investigators from HeH reported that HeH participants
are more likely to be female, white/non-Hispanic,
college-educated, nonsmokers, in excellent general health, but
are also more likely to have cardiovascular disease and risk
factors, compared with a national research study with more
traditional recruitment practices [13]. Moreover, the level of
technical support that may be required by participants for
mHealth device data collection is unclear, especially with regard
to middle-aged and older adults who may have less familiarity
and require more support with mHealth technology [16]. Finally,
despite several theoretical advantages of merging these newer
remote studies (lacking on-site visits) with established
conventional cohorts, this practice has not yet been carefully
studied [6].
Objectives
We conducted a 5-month pilot study in the well-characterized
Framingham Heart Study (FHS) cohort to test the feasibility of
incorporating mHealth technology in a long-standing
epidemiologic cohort study using remote versus in-person device
set up. Our approach to pilot test and scale up the use of mHealth
technology and electronic surveys (e-surveys) within FHS [17]
leveraged the committed study participants and infrastructure
of FHS. For the pilot study, we partnered with the HeH Study,
which had an established protocol and infrastructure for
collecting mHealth data.
The main purpose of our FHS-HeH pilot study was to assess
whether remote mHealth data collection supported by email
was equivalent to a strategy that involved in-person support
on-site at the FHS Research Center by measuring the rates of
mHealth device set up and continued use over the 5-month
study. In addition to testing the feasibility and optimal data
collection strategy, we also assessed the clinical characteristics
of enrolled versus declined participants, completion rates of
internet-based self-report data, and study design acceptability
among participants.
Methods
Study Design
The FHS began enrolling participants for the Original cohort
in 1948 [18]. In 1971, the offspring of the Original cohort and
the spouses of these offspring were enrolled in the Offspring
study [19]. In 1994 and 2002, ethnic/racial minority Omni
cohorts were recruited to increase the diversity represented in
FHS to better reflect the contemporary diversity of the town of
Framingham, Massachusetts. In addition, in 2002, Third
Generation participants were recruited from a sample of
individuals that had at least 1 parent in the Offspring cohort
[20]. These participants have been followed at 2- to 8-year
intervals in the subsequent years and the study is ongoing. The
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most recent Offspring examination (including Omni cohort 1)
occurred between 2011 and 2014 and the last Third Generation
(including Omni cohort 2) examination was conducted during
2008 to 2011. Previous FHS examinations primarily used phone
calls to recruit participants to return to the FHS Research Center.
FHS Offspring, Third Generation, and Omni participants [19,20]
who had an email address, lived within a 1-hour drive of the
FHS Research Center and owned an iPhone [21] were eligible
for participation in this investigation. The iPhone requirement
was included as, at the time, not all devices were supported by
Android. A previous report from FHS, Framingham Digital
Connectedness Survey, permitted us to identify participants
reporting iPhone ownership and internet use for recruitment
purposes [21]. During the recruitment (May-October 2015),
363 participants were sent an email invitation Figure 1. Our
goal was to recruit 100 participants in each of the study arms
(remote vs on-site support) and to sample at least 20% older
participants (age ≥65 years). Our study protocol followed Zelen
design [22], in which participants were randomized to one of
the following 2 groups before invitations were sent and consent
was obtained:
Figure 1. Flow chart of recruitment and initial device connection for the Framingham Heart Study–Health eHeart pilot study. Pending/unenrolled
participants responded to the initial email invitation, but they did not respond to further communications. FHS: Framingham Heart Study; iH: iHealth;
AliveCor: electrocardiogram device.
• Remote support: Participants randomized to the remote
support group received an email invitation with an
explanation about the FHS-HeH pilot study and a URL they
could follow to learn more and register for the study (first
figure, Multimedia Appendix 1). For those who did not
register within 1 week of the initial email, a second email
was sent. After a second week of no response, a phone call
was placed to their home. No more than 3 phone calls were
placed to any individual for recruitment purposes.
• On-site support: Participants randomized to the on-site
support group were contacted by the same email/phone call
protocol to register for the study and set up a study visit
(second figure, Multimedia Appendix 1). Trained FHS staff
members assisted the participants in-person to register with
the FHS-HeH pilot study, sign the Web-based consent, and
connect the devices to their iPhones and the study website.
If requested, participants were able to return to the FHS
Center if they required additional in-person support.
After the study termination (March 2016), all participants were
emailed an end-of-study survey, through an internet link, to
assess the participant burden and the overall FHS-HeH
experience. The survey went out after 98% of the participants
had completed the 5-month study (4 participants had not yet
completed 5 months). The FHS-HeH study was approved by
the Institutional Review Board (IRB) at the University of
California, San Francisco, and the participants provided written
informed consent. The Boston University Medical Center had
an approved IRB authorization agreement.
Covariates
The following demographic information was collected from the
most recent FHS examination attended: age, sex, body mass
index (BMI), physical activity index [23], history of smoking
(defined as former or current smokers, having at least 1 cigarette
per day in the past year), hyperlipidemia (total cholesterol ≥200
mg/dL or being on lipid treatment), education, diabetes mellitus
(defined as fasting glucose ≥126 mg/dL or treatment with
hypoglycemic agent or insulin), hypertension (defined as systolic
BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or being on
treatment), atrial fibrillation, and cardiovascular disease
(includes myocardial infarction, coronary insufficiency,
atherothrombotic brain infarct, transient ischemic attack,
intermittent claudication, and heart failure). Participants with
missing demographic data (detailed in the Results section) either
did not attend their last FHS examination cycle or did not
complete that part of the examination. Participants with missing
covariate data were included in all tables.
Statistical Analysis
Demographic information was reported as mean (SD) for each
study arm and for FHS participants who declined to participate
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in this investigation. Study adherence was defined
conservatively as simply taking 1 measurement each month to
get a broad assessment of continued device use. Study adherence
and survey responses were compared between the 2 study arms
in the total study sample by calculating the mean percent
differences and 95% CIs. All statistical analyses were performed
by using SAS, version 8 (SAS Institute Inc). Significant
differences were reported at the P<.05 level.
Results
Study Enrollment
Of the 363 participants invited, 87 participants did not respond
to the initial recruitment efforts, 38 declined to participate, and
36 communicated an intent to participate but did not follow
through with enrollment (Figure 1). There were 101 participants
who completed enrollment in each of the randomized study
arms (n=202 total). Owing to the 2 early withdrawals (1
withdrawal in each study arm), additional participants were
allowed to enroll to replace these withdrawals. In the on-site
arm, there was a study technician available to answer questions
and we observed 100% completion of the consent process. In
contrast, individuals in the remote arm were emailed a link to
initiate the consent process; only 93/101 (92%) completed the
consent. In total, 82 participants responded to the invitation but
did not complete the consent (38 participants declined, 36 were
pending/not enrolled, and 8 enrolled but did not complete
consent). Consenting participants were more likely to be women,
tended to be younger, were less likely to smoke or have diabetes
mellitus, and were more likely to have attended at least some
college (Table 1). The rates of missing demographic data from
Table 1 were low (BMI, missing [m]=11; physical activity index,
m=13; history of smoking, m=3; hyperlipidemia, m=11;
education, m=5; diabetes mellitus, m=15; and hypertension,
m=11). Missing data were because of either missing the most
recent FHS examination or missing the questionnaire/biomarker
data at the most recent examination. None of the participants
missing diabetes mellitus data had a diagnosis of diabetes
mellitus on FHS examinations that occurred before the most
recent FHS examination.
Table 1. Demographic information from study participants collected at their last Framingham Heart Study examination.
P value for difference
between consented and
not consentedb
Responded to invitation, but
not consenteda (n=82)
Consented to study (n=194)Demographics
Randomized to remote
arm (n=93)
Randomized to on-site
arm (n=101)
.00958 (12)53 (10)55 (11)Age (years), mean (SD)
.0438 (46)57 (61)60 (59)Women, n (%)
Cohort, n (%)
—
c30 (37)12 (13)19 (19)Offspring
—49 (60)75 (81)76 (75)Third Generation
———2 (2)Omni 1
—3 (4)6 (6)4 (4)Omni 2
Education, n (%)
————Less than high school
—14 (17)3 (3)6 (6)High school
—17 (21)19 (20)10 (10)Some college
—51 (62)71 (76)85 (84)College and higher
.4828 (6)29 (6)27 (5)Body mass index (kg/m2), mean (SD)
.2636 (5)35 (7)35 (5)Physical Activity Index, mean (SD)
.00229 (35)21 (23)15 (15)History of smoking, n (%)
.9940 (50)47 (53)47 (46)Hyperlipidemia, n (%)
.098 (10)2 (2)5 (5)Diabetes mellitus, n (%)
.8719 (24)22 (25)20 (20)Hypertension, n (%)
.994 (5)7 (8)2 (2)Cardiovascular disease, n (%)
.991 (1)1 (1)2 (2)Atrial fibrillation, n (%)
aThe not consented column includes 38 participants who declined, 36 pending/not enrolled, and 8 enrolled but did not complete consent.
bP values were not calculated for differences in cohort and education because of low numbers in some groups.
cNot applicable.
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Importantly, recruitment of the older adults (age ≥65 years) for
this e-Cohort study was less efficient (50% of individuals
consented, 27 out of the 54 individuals who responded to the
email invitation to participate) compared with the recruitment
of adults aged <65 years (75% consented, 167 out of the 222
individuals who responded to the email invitation), as calculated
from Table 1 and the first table of Multimedia Appendix 1.
Older adults choosing to participate in our study had completed
more education (100% completing at least some college) than
those choosing not to participate, of which 26% (n=7/27) had
not continued on to college after high school.
Device Use
In the on-site arm, 99% of the consenting participants (100/101)
initially connected to the Fitbit device, 95% (96/101) to the
iHealth BP cuff and scale, and 84% (85/101) to the AliveCor
ECG. As for the remote arm, 74% of those that consented
initially (69/93) connected to the Fitbit device, 73% (n=68/93)
to the iHealth BP cuff, 75% (70/93) to the iHealth scale, and
41% (38/93) to the AliveCor ECG (Figure 1 and Table 2). The
on-site arm had 20% to 43% more participants initially
connected to the devices at baseline (mean percent difference
was 25% [95% CI 17-35] for activity monitor, 22% [95% CI
12-32] for BP cuff, 20% [95% CI 10-30] for scale, and 43%
[95% CI 30-55] for ECG).
After the initial connection, the proportion of participants that
continued to use the devices declined consistently in both arms
of the study (Table 3 and Figure 2). Although 4 study
participants in the on-site arm did not have the opportunity to
participate in the full 5-month study, removal of these
participants in sensitivity analyses did not change the results
considerably (second and third table of Multimedia Appendix
1).
Table 2. Primary analysis: Rate of device connection at baseline and continued use at 5 months.
Difference in proportion of device connection rate
between study arms
Remote (n=93), n (% consent)On-site (n=101), n (% consent)Device
Mean percent differ-
ence between study
arms in fifth month de-
vice use rate (95% CI)
Mean percent differ-
ence between study
arms in baseline connec-
tion rate (95% CI)
Fifth month
device use
Baseline connectionFifth month
device usea
Baseline connection
20 (7 to 33)25 (17 to 35)54 (58)69 (74)79 (78)100 (99)Fitbit device
10 (−4 to 24)22 (12 to 32)40 (43)68 (73)54 (53)96 (95)iHealth blood pressure
cuff
13 (−1 to 27)20 (10 to 30)40 (43)70 (75)57 (56)96 (95)iHealth scale
18 (4 to 31)43 (30 to 55)33 (35)38 (41)54 (53)85 (84)AliveCor
aA total of 4 participants in the on-site arm did not have the opportunity to participate for the full 5 months owing to study termination.
Table 3. Secondary analysis: Continued use of devices for participants who were initially able to connect to the devices during the first month. The n
(%) values are given with regard to baseline device connection.
Difference in proportion of continued device
use between study arms
Remote (N=93)On-site (N=101)Device
Mean percentage
difference between
study arms in fifth
month device use
rate (95% CI)
Mean percentage
difference between
study arms in base-
line connection rate
(95% CI)
Fifth month
device use, n
(% baseline)
Third month
device use, n
(% baseline)
Baseline
connection,
n
Fifth month
device use, n
(% base-
line)a
Third month
device use, n
(% baseline)
Baseline
connection,
n
1 (−12 to 14)−4 (−14 to 6)54 (78)63 (91)6979 (79)87 (86)100Fitbit device
−3 (−18 to 13)8 (−6 to 23)40 (59)44 (65)6854 (56)70 (69)96iHealth
blood pres-
sure cuff
2 (−13 to 17)11 (−3 to 26)40 (57)43 (61)7057 (59)70 (69)96iHealth scale
−23 (−37 to −6)−5 (−9 to 11)33 (87)32 (84)3854 (64)67 (66)85AliveCor
aA total of 4 participants in the on-site arm did not have the opportunity to participate for the full 5 months owing to study termination.
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Figure 2. Number of participants using devices throughout the study from study enrollment through the 5-month follow-up period. BP: blood pressure.
Survey Data
All consenting participants were sent links to participate in the
2 internet-based surveys: a baseline core survey and an
end-of-study survey after the study termination. The baseline
core survey comprised 34 separate parts assessing self-reported
health outcomes that could be completed in any order and was
well attended by participants in both arms. The first survey was
completed by 83 (82%) participants from the on-site arm and
89 (96%) participants from the remote arm (Figure 1.) After the
study completion, all participants were sent an end-of-study
survey, of which only 63% of the on-site arm and 45% of the
remote arm participated (fourth table, Multimedia Appendix
1). Overall, the participants endorsed positive statements about
their study participation. At least 95% of the participants in both
study arms agreed to the statement, “I would participate in this
type of study again in the future.” Over 85% of the participants
in the on-site arm agreed with almost all the survey questions
(as demonstrated by the shaded boxes in the fourth table of
Multimedia Appendix 1), whereas there was slightly lower
agreement for the remote arm.
Discussion
Principal Findings
Our FHS-HeH pilot study was conducted in collaboration with
the HeH Study to test feasibility of mHealth and digital data
collection in FHS participants using remote versus in-person
support for device set up and use over a 5-month period.
Participants in our on-site study arm had the opportunity to visit
the FHS Research Center for consent and mobile device set up.
We observed that the on-site participants were more likely to
consent and had better success with initial device connection
and use compared with the individuals who received only remote
support by phone or email. However, once connected to the
devices, the rates of continued device use were similar in both
groups. Our findings suggest that it is possible to maximize
participation by leveraging in-person support for e-Cohort
studies. Furthermore, we observed reasonable adherence with
mHealth technology by older adults.
In both study arms combined, almost 79% of the participants
who successfully initialized the Fitbit device at the beginning
of the study continued to use the device for the full 5-month
study, representing 69% of the total sample of consenting study
participants. We defined continued use very conservatively, as
1 measurement per month, to get a broad assessment of
continued device use. Preliminary data from a new FHS
initiative separate from FHS-HeH, called eFHS, reported that
76% (306 of 402 participants given an Apple Watch device)
wore the device at least weekly over 3 months and received
reminder messages if no data were sent for 14 days [17].
In 2 other studies that recruited participants using snowball
(social network/internet-based) sampling strategies specifically
to enroll participants into e-Cohort studies, surprisingly, the
frequency of device use did not appear to be more successful,
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and may have even been lower, than in FHS-HeH or eFHS
which enrolled from within the ongoing FHS cohort [14,24].
In the MyHeart Counts study, investigators reported that 47%
of their >48,000 consented study participants completed just 2
consecutive days of fitness monitor data as measured by a
smartphone app in the first week and adherence only declined
from there [14]. In the mPower substudy of HeH, a 6-month
smartphone-based study, 87% of 9520 study participants
completed at least one task on the smartphone app after
consenting to the study, but only 9% contributed data on ≥5
separate days, confirming that consistency in device or app use
is one of the major challenges of this type of research [24].
Physical activity intervention studies provide additional
comparative data, with considerable drop-off in device use over
the short term (3-6 months) and over longer periods (6 months
to 1 year), especially after the participant incentives are
terminated [25-27]. Unfortunately, owing to our study
termination after at least 5-months follow-up, we are unable to
test whether there would be an effect of device setup strategy
(on-site versus remote) on longer follow-up of continued device
use. It is also unclear what type of communication, support, or
incentives might maximize adherence with mHealth devices.
In our study, participants were only sent reminders to sync their
devices, briefly, midstudy. Our study was not designed to assess
whether these reminders affected device use. However, there
is a burgeoning field of study testing communication
methods/strategies to increase and sustain health behavior
[28-31]. Messaging may need to be tailored to participants based
on the current adherence, and investigators should be cautious
that the language does not infer that data are not received, unless
that is the message meant to be communicated.
Overall use of the BP cuff, scale, and AliveCor ECG were
somewhat lower than the continued use of the Fitbit device in
our FHS-HeH on-site arm, but generally, once connected, the
use was similar for both the study arms. Across both arms, 56%
to 59% of the participants who successfully connected the BP
cuff or scale at baseline, continued to use it through the 5-month
study duration. For comparison, in a meta-analysis, rates of
adherence to self-monitoring BP in hypertensive patients
participating in an intervention to lower BP varied widely by
study, but true comparison with our study is difficult as most
of our FHS-HeH participants were not hypertensive [32]. In
addition, most studies from the meta-analysis used traditional
nonconnected BP devices, instead of mHealth devices with
smartphone apps.
Device connection to the AliveCor ECG device was lower than
other devices. Our technical staff reported that the AliveCor
was typically the last device they connected during the in-person
visit. Another contributing factor could be the more complex
instructions for setting up the AliveCor device, including
multiple steps in which the participants were required to log in
to their email. Other than these reasons, it is unclear why the
connection rates were much lower in the remote arm (41%)
compared with the on-site arm (84%).
In contrast to the diminishing rates of the BP cuff or scale use
over time, the rate of continued adherence for those that were
initially able to connect to the AliveCor ECG remained relatively
high at 5 months (especially in the remote arm, 87%). However,
enthusiasm about apparently high AliveCor adherence should
be tempered by the fact that only a small number of participants
connected to this device at baseline. Thus, participants who
successfully connected to the AliveCor at baseline may differ
from those who connected to other devices. We hypothesize
that AliveCor users may be more interested in their health, more
motivated study participants, and/or more technologically savvy.
However, one limitation to our study is that we did not measure
the reasons for differences in device use, so we are not able to
determine the facilitators and barriers to the use of specific
devices [13,14,16,33,34].
Internet-Based Survey Data Can Be Successfully
Administered Via Different Strategies
In addition to answering important questions about device
connection and use, our study was able to assess the rate of
internet-based survey initiation using our 2 study arms. Until
recently, the FHS has conducted most questionnaires in-person
and only administered short health history updates in the interim
between examinations by phone or using traditional mail via
the postal service. Although consent and device connection
appeared more successful in the on-site arm of the study, the
participation in the baseline core survey was higher in the remote
arm (82% vs 96% in the on-site and remote arms, respectively).
Therefore, in-person contact may not be an important part of a
study designed only to perform surveys with participants.
Instead, higher survey participation rates in the remote arm may
be reflective of the lower burden imposed initially in the remote
arm before devices were shipped. These results provide some
evidence that internet-based surveys may be effective means to
conduct a health history questionnaire in FHS participants.
Other e-Cohort studies have had variable success with
participant engagement in e-surveys, which may depend on the
timing and strategies used to present surveys to participants. In
MyHeart Counts, 41% of the study participants completed a
cardiovascular health survey, whereas 73% completed a physical
activity survey, and only 17% provided race/ethnicity [14]. The
HeH Study (with >210,000 participants) reported that 86% of
participants completed at least one survey, but 37% provided
complete survey data [13]. Another traditional cardiovascular
epidemiology cohort, Coronary Artery Risk Development in
Young Adults has also explored the electronic administration
of surveys through the internet (eCARDIA), reporting 52%
survey completion [35]. On the basis of the results from these
studies, it may be important to prioritize survey administration
in e-Cohort studies to ensure that the most important surveys
have strong adherence.
In contrast to the high participation rates in the baseline core
survey, the end-of-study survey was not completed as frequently
(62% vs 45% of on-site and remote participants, respectively).
Study design and communication with participants are not only
important for the baseline connection and use of the device, but
also for good adherence to device use at follow-up. These
considerations are especially important for longitudinal studies
that continue to engage participants over a long follow-up period
as poor communication and frustration from participants may
impact future participation. On the basis of data from
approximately half of the study participants who provided
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feedback, approximately 96% of the participants said that they
would participate in this type of study again, regardless of the
study arm. Although participation bias influences our ability to
interpret results from the end-of-study survey, it does appear
that the on-site participants responded more favorably overall.
Strengths, Bias, and Limitations of Our Study Design
The strengths of our study lie in our study design, which
leveraged infrastructure and the strengths of FHS and HeH,
including a recruitment sample of committed study participants
across middle and older age. Our design not only enabled the
examination of different methodologies for incorporating
consumer-facing mHealth technology into an epidemiological
study, but may also provide insight for other study designs,
including clinical trials.
Important limitations to consider include the limited exploration
of participation bias by demographic factors other than age. The
study was small, and we had limited power to examine subgroup
findings. The FHS primarily comprises white individuals
residing in New England; therefore, we were unable to analyze
how the study design influenced participation by racial/ethnic
group or region. Certain demographic groups may be more
unlikely to be eligible for participation in mHealth studies, such
as those that do not have a smartphone [21]. In our FHS Digital
Connectedness Survey, administered during 2014 to 2015, we
reported that smartphone users in FHS were younger, more
highly educated, with less cardiovascular risk factors than
individuals without a smartphone [21]. However, even among
the participants who were eligible for our study (ie, had an
iPhone and email address), those who agreed to participate were
more likely to have attended at least some college (95% vs 82%
among participants who were eligible but declined to participate)
and were less likely to be smokers. Both trends are similar to
what was seen in other e-Cohort studies [35,36], including the
preliminary HeH recruitment analysis in which participants
were less likely to smoke and were more likely to be women,
had higher educational attainment, reported excellent general
health, and were likely to be white (rather than black, Hispanic,
or Asian) when compared with the traditional National Health
and Nutrition Examination Survey study design [13]. Although
issues of generalizability plague all epidemiological studies, it
may be a particular concern in e-Cohort studies.
Previous studies in minority communities in the United States
cited concerns and misconceptions by the participants in
mHealth studies, such as the type of information that would be
tracked by mobile technology, legal risks that might be
introduced through participation, a lack of familiarity with
certain devices, and unwanted attention from others when
wearing or using devices in public [37,38]. These concerns can
impact both study participation and adherence and may require
cultural sensitivity (or age/generational sensitivity), creativity,
and patience from the study team. The study team must weigh
cost-effectiveness of potential adaptations, with limiting
selection bias and maximizing the equity in research across
diverse populations [37,38]. We did not analyze the cost between
the study arms, so we are not able to compare the differences
in our study. It is possible that personal communications with
knowledgeable study coordinators and the research team may
help to overcome some of the barriers mentioned above. The
introduction of mHealth technology raised some concerns even
in FHS participants who are familiar with research studies. We
observed a barrier to consent that was somewhat overcome
through the on-site study design, in which participants spoke
with study coordinators who could explain the study, answer
questions, and provide in-person support for setting up the
mHealth devices. Future studies should assess whether other
forms of participant engagement, such as text messaging, will
influence mobile device use and study adherence.
We also acknowledge the conservative measure of study
adherence (device use once per month) as we were most
interested in assessing the overall adherence as a primary study
aim. In future studies, it will also be important to understand
the barriers preventing study adherence and to investigate the
factors contributing to the frequency of use and how to improve
these metrics. We acknowledge that providing 4 devices might
have been burdensome for some participants, especially as
participants needed to visit 3 different consumer-facing
websites/apps to create accounts for each device (iHealth, Fitbit,
and AliveCor) to connect the devices to the HeH platform,
adding complexity to the initial user experience. Using 1 single
app to connect multiple devices may improve connection for
participants, especially for participants connecting remotely.
Another key future step will be testing different methods of
supporting and engaging participants, including assessing how
participants engage with the website/apps using Web analytics
tools. Providing in-person support, as we showed in our
FHS-HeH pilot study, has the potential to increase study
efficiency and may also minimize participation bias.
Conclusions
Our feasibility study demonstrated that offering on-site support
for studies involving mHealth technology maximizes
participation and initial rates of device use, compared with
offering only remote support. However, once connected,
drop-off rates were similar in both groups. Future studies may
find it to be cost-effective to provide in-person support for
studies involving mHealth technology for middle-aged and older
populations.
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